Patent · US Active

Combination therapy

US9603851B2 · kind B2 · utility

0Cited by

145References

2Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Thomas KLEIN · Radolfzell, DE
Rolf GREMPLER · Mittelbiberach, DE
Michael Mark · Biberach an der Riß, DE

Key dates

Filing date	Oct 2, 2015
Grant date	Mar 28, 2017
Priority date	—
Expiry date	Oct 2, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.